Effect Of Cryolipolysis On Visceral Adiposity Index In Polycystic Ovarian Syndrome Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04745338

Enrollment

Registered

2021-02-09

Start date

2021-03-01

Completion date

2022-02-28

Last updated

2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Brief summary

this study will be carried to investigate the effect of cryolipolysis on visceral adiposity index in pco women randomized controlled trial

Detailed description

This study will be carried out on sixty females with polycystic ovarian syndrome (PCOS) who were selected from the Outpatient Clinic of Gynecology at Qasr Al Aini University Hospital. Their age ranged from 17-28 years, body mass index was 25-30 Kg/m2. They experienced hyperandrogenism, hyperinsulinemia and amenorrhea not less than 6 months. PCOS females will be randomly assigned into two equal groups: group (A) (control group) consisted of 30 women who received low caloric diet (1200 Cal/day) and group (B) (study group) consisted of 30 women who received the same diet regime and cryolipolysis

Interventions

DEVICE3max cool shaping device

cryolipolysis sessions are applied on abdomen area each session for 40 min. each

DIETARY_SUPPLEMENTlow calolric diet

low caloric diet (1200cal/day)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 28 Years

Healthy volunteers

Yes

Inclusion criteria

* age ranges from 20-28 years, body mass index ranges 25-30 Kg/m2. They have pco syndrome .

Exclusion criteria

* Diabetic patients. * Women with BMI\>30 * Women having circulatory dysfunction. * Women with respiratory or cardiac disease * liver disease. * Skin disease . * Previous abdominal or uterine surgery * Physical impairment

Design outcomes

Primary

Measure	Time frame	Description
Visceral adiposity index	3 months	indicator of adipose tissue distribution

Secondary

Measure	Time frame	Description
weight	up to 3 months	anthropometric measurement by kilogram (kg)
waist circumference	up to 3 months	anthropometric measurement by centimeter (cm)
high density lipoprotein	up to 3 months	blood test
serum triglyceride level	up to 3months	blood test

Countries

Egypt

Contacts

Primary Contactmiral mo saleh, md

marmooramido@gmail.com01200678845

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026